I
Imerio Angriman
Researcher at University of Padua
Publications - 149
Citations - 3151
Imerio Angriman is an academic researcher from University of Padua. The author has contributed to research in topics: Crohn's disease & Inflammatory bowel disease. The author has an hindex of 27, co-authored 133 publications receiving 2697 citations.
Papers
More filters
Journal ArticleDOI
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease
Julián Panés,Damián García-Olmo,Gert Van Assche,Jean-Frederic Colombel,Walter Reinisch,Walter Reinisch,Daniel C. Baumgart,Axel Dignass,Maria Nachury,Marc Ferrante,Lili Kazemi-Shirazi,Jean Charles Grimaud,Fernando de la Portilla,Eran Goldin,Marie Paule Richard,Mary Carmen Diez,Ignacio Tagarro,Anne Leselbaum,Silvio Danese,Jean Fred Colombel,Anton Stift,Jörg Tschmelitsch,Karl Mrak,Herbert Tilg,Irmgard Kroberger,André D'Hoore,Danny De Looze,Filip Baert,Paul Pattyn,Philippe Zerbib,Frank Zerbib,Stephanie Viennot,Jean-Louis Dupas,Pierre-Charles Orsoni,Xavier Hébuterne,Amine Rahili,Matthieu Allez,Yves Panis,Max Reinshagen,Roland Scherer,Andreas Sturm,Wolfgang Kruis,Daniel-Simon Duek,Matti Waterman,Adi Lahat-Zok,Oded Zmora,Hagit Tulchinsky,Y. Edden,Antonino Spinelli,Vito Annese,Imerio Angriman,Gabriele Riegler,Francesco Selvaggi,Bas Oldenburg,Lennard Gilissen,Gust Van Montfort,Mark Löwenberg,Adrianus Willem Bemelman,Raúl Almenara,María Dolores Martín Arranz,Mariano García-Arranz,Javier P. Gisbert,Rosana Palasí,Carlos Taxonera Samso,José Manuel Herrera Justiniano,Ricardo Rada,Mª Teresa Butrón,Daniel Carpio López,Antonio López-Sanromán,Joaquín Hinojosa de Val,Amparo Solana,F. Xavier González Argenté,Carlos Pastor,Héctor Guadalajara +73 more
TL;DR: In a phase 3 trial of patients with Crohn's disease and treatment-refractory complex perianal fistulas, Cx601 is found to be safe and effective in closing external openings, compared with placebo, after 1 year.
Journal ArticleDOI
European evidence based consensus on surgery for ulcerative colitis.
Tom Øresland,Willem A. Bemelman,Gianluca M. Sampietro,Antonino Spinelli,Alastair Windsor,Marc Ferrante,Philippe Marteau,Oded Zmora,Paulo Gustavo Kotze,Eloy Espin-Basany,Emmanuel Tiret,Giuseppe S. Sica,Yves Panis,Arne Engebreth Færden,Livia Biancone,Imerio Angriman,Zuzana Serclova,Anthony de Buck van Overstraeten,Paolo Gionchetti,Laurents P. S. Stassen,Janindra Warusavitarne,Michel Adamina,Axel Dignass,Rami Eliakim,Fernando Magro,André D'Hoore +25 more
TL;DR: The goal of this consensus initiated by the European Crohn's and Colitis Organisation (ECCO) was to establish European consensus guidelines for the surgical treatment of ulcerative colitis and the strategy to reach the consensus involved several steps and follows the standard operating procedures for consensus guidelines of ECCO.
Journal ArticleDOI
A systematic review on the clinical diagnosis of gastrointestinal stromal tumors.
TL;DR: The aim of this work was to assess the prevalence of symptoms of gastrointestinal stromal tumors and the diagnostic yield of clinical procedures for its diagnosis.
Journal ArticleDOI
Enzymes in feces: Useful markers of chronic inflammatory bowel disease
Imerio Angriman,Marco Scarpa,Renata D'Incà,Daniela Basso,Cesare Ruffolo,Lino Polese,Giacomo Carlo Sturniolo,Davide F. D'Amico,Mario Plebani +8 more
TL;DR: Fecal markers are non-invasive, simple, cheap, sensitive and specific parameters and are useful to detect strointestinal inflammation in IBD patients.
Journal ArticleDOI
Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia.
Renata D'Incà,Romilda Cardin,L. Benazzato,Imerio Angriman,Diego Martines,Giacomo Carlo Sturniolo +5 more
TL;DR: Oxidative DNA damage accumulates with the duration of the disease in ulcerative colitis reaching maximal increase if dysplastic lesions are found with possible implications for mutagenic and carcinogenic progression.